BI
RNTX

BVF Inc’s Rein Therapeutics RNTX Stock Holding History

BVF Inc’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-236,835
Closed -$561K – 80
2022
Q4 		$561K Sell
236,835
-26,443
-10% -$88.8K 0.02% 75
2022
Q3 		$1.09M Hold
263,278
– – 0.04% 74
2022
Q2 		$1.37M Hold
263,278
– – 0.07% 71
2022
Q1 		$2.7M Hold
263,278
– – 0.11% 70
2021
Q4 		$2.96M Hold
263,278
– – 0.11% 75
2021
Q3 		$5.37M Hold
263,278
– – 0.22% 64
2021
Q2 		$6.58M Hold
263,278
– – 0.25% 56
2021
Q1 		$7.53M Buy
+263,278
New +$9.02M 0.28% 55

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return